ABVC BioPharma, Inc. Convertible Notes Payable, Current
ABVC BioPharma, Inc. (ABVC) had Convertible Notes Payable, Current of $254.19 thousand as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2025-08-13
- 2025-06-30: Convertible Notes Payable, Current $254.19K.
- 2024-12-31: Convertible Notes Payable, Current $950.05K.
- 2024-06-30: Convertible Notes Payable, Current $956.88K.
- 2024-03-31: Convertible Notes Payable, Current $842.57K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2025-06-30 | $254.19K 10-Q · filed 2025-08-13 |
| 2024-12-31 | $950.05K 10-Q · filed 2025-08-13 |
| 2024-06-30 | $956.88K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $842.57K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $569.46K 10-Q · filed 2024-08-14 |
| 2020-09-30 | $250.00K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $820.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $820.00K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $820.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $820.00K 10-Q · filed 2019-11-18 |
| 2019-06-30 | $460.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-28 |
| 2018-12-31 | $300.00K 10-K · filed 2020-05-15 |